Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

59.01
-0.7400-1.24%
Post-market: 59.010.00000.00%16:20 EDT
Volume:724.31K
Turnover:42.59M
Market Cap:2.78B
PE:-128.69
High:59.89
Open:59.64
Low:58.15
Close:59.75
Loading ...

Press Release: Aptose Reports Year End 2024 Results and Corporate Highlights

Dow Jones
·
28 Mar

Ashland to host 2025 Innovation Day for analysts and investors

GlobeNewswire
·
28 Mar

Ashland Is Maintained at Overweight by Wells Fargo

Dow Jones
·
27 Mar

Press Release: CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress

Dow Jones
·
27 Mar

Press Release: ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update

Dow Jones
·
27 Mar

Ashland (ASH) Gets a Buy from Wells Fargo

TIPRANKS
·
27 Mar

Press Release: Keymed Biosciences Announces Annual Results of 2024

Dow Jones
·
26 Mar

Paychex Posts Better-Than-Expected Earnings, Joins Worthington Enterprises, GameStop, Cintas And Other Big Stocks Moving Higher On Wednesday

Benzinga
·
26 Mar

Ashland Raised to Overweight From Neutral by JP Morgan

Dow Jones
·
26 Mar

JPMorgan Upgrades Ashland to Overweight From Neutral, Adjusts Price Target to $71 From $68

MT Newswires Live
·
26 Mar

U.S. RESEARCH ROUNDUP-Ashland, Connectone Bancorp, Neurocrine Biosciences

Reuters
·
26 Mar

Ashland Inc : JP Morgan Raises to Overweight From Neutral; Raises Target Price to $71 From $68

THOMSON REUTERS
·
26 Mar

X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
25 Mar

Press Release: SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update

Dow Jones
·
21 Mar

Press Release: Autolus Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

Dow Jones
·
20 Mar

Ashland Wraps Up Divestment of Avoca Business to Mane

Zacks
·
18 Mar